Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
BENDEKA® is indicated for the treatment of patients with chronic lymphocytic leukemia. Efficacy relative to first line therapies other than chlorambucil has not been established. BENDEKA is indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
- generic_name
- bendamustine hydrochloride
- product_names
- bendamustine hydrochloride
- ndc
- 63459-348, 63459-348-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en